RELATIONSHIP BETWEEN PLASMA OXIPURINOL CONCENTRATIONS AND XANTHINE-OXIDASE ACTIVITY IN VOLUNTEERS DOSED WITH ALLOPURINOL

被引：32

作者：

DAY, RO ^{[1
]}

MINERS, J ^{[1
]}

BIRKETT, DJ ^{[1
]}

GRAHAM, GG ^{[1
]}

WHITEHEAD, A ^{[1
]}

机构：

[1] FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT CLIN PHARMACOL,BEDFORD PK,SA 5042,AUSTRALIA

来源：

关键词：

D O I：

10.1111/j.1365-2125.1988.tb03402.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：429 / 434

页数：6

共 26 条

[1] Auscher C, 1974, Adv Exp Med Biol, V41, P663
[2] BERGMANN F, 1956, J BIOL CHEM, V223, P765
[3] BIRKETT DJ, 1985, DRUG METAB DISPOS, V13, P725
[4] SECONDARY METABOLISM OF THEOPHYLLINE BIOTRANSFORMATION PRODUCTS IN MAN - ROUTE OF FORMATION OF 1-METHYLURIC ACID
BIRKETT, DJ
MINERS, JO
ATTWOOD, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (01) : 117 - 119
[5] BIRKETT DJ, 1987, ENZYME INDUCTION MAN, P71
[6] CONVERSION OF 4-HYDROXYPYRAZOLO[3,4-D]PYRIMIDINE (ALLOPURINOL) INTO 4,6-DIHYDROXYPYRAZOLO[3,4-D]PYRIMIDINE (OXIPURINOL) IN VIVO IN ABSENCE OF XANTHINE-OXYGEN OXIDOREDUCTASE
CHALMERS, RA
PARKER, R
SIMMONDS, HA
SNEDDEN, W
WATTS, RWE
[J]. BIOCHEMICAL JOURNAL, 1969, 112 (04) : 527 - &
[7] DAY RO, 1988, BR J CLIN PHARM, V26, P425
[8] METABOLIC STUDIES OF ALLOPURINOL AN INHIBITOR OF XANTHINE OXIDASE
ELION, GB
KOVENSKY, A
HITCHING.GH
METZ, E
RUNDLES, RW
[J]. BIOCHEMICAL PHARMACOLOGY, 1966, 15 (07) : 863 - &
[9] ELION GB, 1978, HDB EXP PHARMACOL, V51, P485
[10] EMMERSON BT, 1987, BRIT J RHEUMATOL, V26, P445